Chunghwa Chemical Synthesis & Biotech Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Chunghwa Chemical Synthesis & Biotech Co Ltd

Watchlist Manager

Watchlist

Price: 33.75 TWD -0.59% Market Closed

Market Cap: NT$2.6B

C	Chunghwa Chemical Synthesis & Biotech Co Ltd TWSE:1762	TW
M	Middle East Pharmaceutical Industries Company SJSC SAU:4016	SA
C	Consolidated Edison Inc F:EDC	US
K	Kyobo 10 Special Purpose Acquisition Co KOSDAQ:355150	KR
	Refex Industries Ltd NSE:REFEX	IN
T	TBH Global Co Ltd KRX:084870	KR
	T Rowe Price Group Inc NASDAQ:TROW	US
	Relo Group Inc TSE:8876	JP
S	Sun Life Financial Inc F:LIE	CA
R	Rheinmetall AG DUS:RHM	DE
A	Alibaba Group Holding Ltd XETRA:AHLA	HK

Profitability Summary

Chunghwa Chemical Synthesis & Biotech Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

18%

Sustainable 3Y Average Gross Margin

24%

Declining Gross Margin

37% > 18%

Negative Operating Margin

-15%

Negative 3Y Average Operating Margin

-5%

Declining Operating Margin

14% > -15%

Negative Net Margin

-6%

Negative 3Y Average Net Margin

-1%

Declining Net Margin

14% > -6%

Exceptional Free Cash Flow Margin

27%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

Negative 3Y Average ROIC

-1%

Declining ROIC

4% > -5%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.